nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—CYP1A2—Phentermine—obesity	0.0799	0.177	CbGbCtD
Leflunomide—CYP1A2—Phenylpropanolamine—obesity	0.0763	0.169	CbGbCtD
Leflunomide—CYP2C9—Phentermine—obesity	0.072	0.159	CbGbCtD
Leflunomide—CYP1A2—Bupropion—obesity	0.068	0.15	CbGbCtD
Leflunomide—CYP2C9—Bupropion—obesity	0.0612	0.135	CbGbCtD
Leflunomide—CYP1A2—Cimetidine—obesity	0.0499	0.11	CbGbCtD
Leflunomide—CYP2C9—Cimetidine—obesity	0.0449	0.0994	CbGbCtD
Leflunomide—Niflumic Acid—SLC16A7—obesity	0.00761	0.931	CrCbGaD
Leflunomide—DHODH—pituitary gland—obesity	0.00406	0.0652	CbGeAlD
Leflunomide—DHODH—adipose tissue—obesity	0.00404	0.0649	CbGeAlD
Leflunomide—PTK2B—respiratory system—obesity	0.00379	0.0609	CbGeAlD
Leflunomide—DHODH—adrenal gland—obesity	0.00363	0.0583	CbGeAlD
Leflunomide—AHR—islet of Langerhans—obesity	0.0033	0.053	CbGeAlD
Leflunomide—DHODH—endocrine gland—obesity	0.00315	0.0505	CbGeAlD
Leflunomide—PTK2B—cardiovascular system—obesity	0.00291	0.0467	CbGeAlD
Leflunomide—DHODH—liver—obesity	0.00284	0.0455	CbGeAlD
Leflunomide—AHR—adrenal cortex—obesity	0.00262	0.042	CbGeAlD
Leflunomide—PTK2B—adipose tissue—obesity	0.00256	0.0411	CbGeAlD
Leflunomide—PTK2B—digestive system—obesity	0.00241	0.0387	CbGeAlD
Leflunomide—PTK2B—adrenal gland—obesity	0.0023	0.0369	CbGeAlD
Leflunomide—AHR—pituitary gland—obesity	0.00212	0.034	CbGeAlD
Leflunomide—AHR—adipose tissue—obesity	0.00211	0.0338	CbGeAlD
Leflunomide—PTK2B—endocrine gland—obesity	0.00199	0.032	CbGeAlD
Leflunomide—AHR—digestive system—obesity	0.00198	0.0318	CbGeAlD
Leflunomide—AHR—adrenal gland—obesity	0.00189	0.0303	CbGeAlD
Leflunomide—PTK2B—liver—obesity	0.0018	0.0289	CbGeAlD
Leflunomide—AHR—endocrine gland—obesity	0.00164	0.0263	CbGeAlD
Leflunomide—AHR—liver—obesity	0.00148	0.0237	CbGeAlD
Leflunomide—CYP1A2—respiratory system—obesity	0.00116	0.0187	CbGeAlD
Leflunomide—ABCG2—adrenal cortex—obesity	0.00102	0.0163	CbGeAlD
Leflunomide—CYP2C9—cardiovascular system—obesity	0.000846	0.0136	CbGeAlD
Leflunomide—ABCG2—pituitary gland—obesity	0.00082	0.0132	CbGeAlD
Leflunomide—ABCG2—adipose tissue—obesity	0.000817	0.0131	CbGeAlD
Leflunomide—CYP1A2—digestive system—obesity	0.00074	0.0119	CbGeAlD
Leflunomide—ABCG2—adrenal gland—obesity	0.000733	0.0118	CbGeAlD
Leflunomide—CYP2C9—digestive system—obesity	0.000703	0.0113	CbGeAlD
Leflunomide—CYP1A2—endocrine gland—obesity	0.000612	0.00982	CbGeAlD
Leflunomide—CYP2C9—endocrine gland—obesity	0.000581	0.00932	CbGeAlD
Leflunomide—ABCG2—liver—obesity	0.000573	0.0092	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—obesity	0.00056	0.0686	CrCbGaD
Leflunomide—CYP1A2—liver—obesity	0.000551	0.00885	CbGeAlD
Leflunomide—CYP2C9—liver—obesity	0.000523	0.0084	CbGeAlD
Leflunomide—Ill-defined disorder—Sibutramine—obesity	0.000243	0.000824	CcSEcCtD
Leflunomide—Anaemia—Sibutramine—obesity	0.000242	0.00082	CcSEcCtD
Leflunomide—Osteoarthritis—Topiramate—obesity	0.000242	0.000819	CcSEcCtD
Leflunomide—Angioedema—Sibutramine—obesity	0.000239	0.000811	CcSEcCtD
Leflunomide—Palpitations—Orlistat—obesity	0.000239	0.00081	CcSEcCtD
Leflunomide—Migraine—Topiramate—obesity	0.000238	0.000806	CcSEcCtD
Leflunomide—Nausea—Cimetidine—obesity	0.000238	0.000805	CcSEcCtD
Leflunomide—Immune system disorder—Bupropion—obesity	0.000237	0.000803	CcSEcCtD
Leflunomide—Mediastinal disorder—Bupropion—obesity	0.000236	0.000801	CcSEcCtD
Leflunomide—Malaise—Sibutramine—obesity	0.000236	0.0008	CcSEcCtD
Leflunomide—Cough—Orlistat—obesity	0.000236	0.0008	CcSEcCtD
Leflunomide—Chills—Bupropion—obesity	0.000235	0.000798	CcSEcCtD
Leflunomide—Vertigo—Sibutramine—obesity	0.000235	0.000797	CcSEcCtD
Leflunomide—Leukopenia—Sibutramine—obesity	0.000234	0.000794	CcSEcCtD
Leflunomide—Arrhythmia—Bupropion—obesity	0.000234	0.000794	CcSEcCtD
Leflunomide—Alopecia—Bupropion—obesity	0.000232	0.000785	CcSEcCtD
Leflunomide—Palpitations—Sibutramine—obesity	0.000231	0.000784	CcSEcCtD
Leflunomide—Myalgia—Orlistat—obesity	0.00023	0.000781	CcSEcCtD
Leflunomide—Chest pain—Orlistat—obesity	0.00023	0.000781	CcSEcCtD
Leflunomide—Mental disorder—Bupropion—obesity	0.00023	0.000779	CcSEcCtD
Leflunomide—Anxiety—Orlistat—obesity	0.00023	0.000778	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000229	0.000775	CcSEcCtD
Leflunomide—Cough—Sibutramine—obesity	0.000229	0.000775	CcSEcCtD
Leflunomide—Malnutrition—Bupropion—obesity	0.000228	0.000774	CcSEcCtD
Leflunomide—Discomfort—Orlistat—obesity	0.000228	0.000771	CcSEcCtD
Leflunomide—Hypertension—Sibutramine—obesity	0.000226	0.000766	CcSEcCtD
Leflunomide—Dry mouth—Orlistat—obesity	0.000225	0.000764	CcSEcCtD
Leflunomide—Flatulence—Bupropion—obesity	0.000225	0.000762	CcSEcCtD
Leflunomide—Dysgeusia—Bupropion—obesity	0.000224	0.000758	CcSEcCtD
Leflunomide—Liver function test abnormal—Topiramate—obesity	0.000223	0.000756	CcSEcCtD
Leflunomide—Myalgia—Sibutramine—obesity	0.000223	0.000756	CcSEcCtD
Leflunomide—Chest pain—Sibutramine—obesity	0.000223	0.000756	CcSEcCtD
Leflunomide—Arthralgia—Sibutramine—obesity	0.000223	0.000756	CcSEcCtD
Leflunomide—Anxiety—Sibutramine—obesity	0.000222	0.000753	CcSEcCtD
Leflunomide—Anaphylactic shock—Orlistat—obesity	0.000221	0.000748	CcSEcCtD
Leflunomide—Back pain—Bupropion—obesity	0.000221	0.000748	CcSEcCtD
Leflunomide—Discomfort—Sibutramine—obesity	0.00022	0.000747	CcSEcCtD
Leflunomide—Hypokalaemia—Topiramate—obesity	0.00022	0.000745	CcSEcCtD
Leflunomide—Muscle spasms—Bupropion—obesity	0.00022	0.000744	CcSEcCtD
Leflunomide—Infection—Orlistat—obesity	0.000219	0.000744	CcSEcCtD
Leflunomide—Breast disorder—Topiramate—obesity	0.000218	0.00074	CcSEcCtD
Leflunomide—Dry mouth—Sibutramine—obesity	0.000218	0.000739	CcSEcCtD
Leflunomide—Toxic epidermal necrolysis—Topiramate—obesity	0.000218	0.000737	CcSEcCtD
Leflunomide—Nervous system disorder—Orlistat—obesity	0.000217	0.000734	CcSEcCtD
Leflunomide—Vision blurred—Bupropion—obesity	0.000215	0.000729	CcSEcCtD
Leflunomide—Skin disorder—Orlistat—obesity	0.000215	0.000727	CcSEcCtD
Leflunomide—Gastritis—Topiramate—obesity	0.000214	0.000724	CcSEcCtD
Leflunomide—Anaphylactic shock—Sibutramine—obesity	0.000214	0.000724	CcSEcCtD
Leflunomide—Hyperhidrosis—Orlistat—obesity	0.000214	0.000724	CcSEcCtD
Leflunomide—Infection—Sibutramine—obesity	0.000212	0.00072	CcSEcCtD
Leflunomide—Ill-defined disorder—Bupropion—obesity	0.000212	0.000718	CcSEcCtD
Leflunomide—Anaemia—Bupropion—obesity	0.000211	0.000715	CcSEcCtD
Leflunomide—Thrombocytopenia—Sibutramine—obesity	0.000209	0.000709	CcSEcCtD
Leflunomide—Asthma—Topiramate—obesity	0.000209	0.000707	CcSEcCtD
Leflunomide—Angioedema—Bupropion—obesity	0.000209	0.000707	CcSEcCtD
Leflunomide—Tachycardia—Sibutramine—obesity	0.000209	0.000707	CcSEcCtD
Leflunomide—Skin disorder—Sibutramine—obesity	0.000208	0.000704	CcSEcCtD
Leflunomide—Eosinophilia—Topiramate—obesity	0.000207	0.0007	CcSEcCtD
Leflunomide—Hyperhidrosis—Sibutramine—obesity	0.000207	0.0007	CcSEcCtD
Leflunomide—Malaise—Bupropion—obesity	0.000206	0.000698	CcSEcCtD
Leflunomide—Vertigo—Bupropion—obesity	0.000205	0.000695	CcSEcCtD
Leflunomide—Pancreatitis—Topiramate—obesity	0.000205	0.000694	CcSEcCtD
Leflunomide—Leukopenia—Bupropion—obesity	0.000204	0.000693	CcSEcCtD
Leflunomide—Anorexia—Sibutramine—obesity	0.000204	0.00069	CcSEcCtD
Leflunomide—Angina pectoris—Topiramate—obesity	0.000203	0.000689	CcSEcCtD
Leflunomide—Sweating increased—Topiramate—obesity	0.000203	0.000689	CcSEcCtD
Leflunomide—Palpitations—Bupropion—obesity	0.000202	0.000684	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Orlistat—obesity	0.000201	0.000682	CcSEcCtD
Leflunomide—Bronchitis—Topiramate—obesity	0.000201	0.00068	CcSEcCtD
Leflunomide—Insomnia—Orlistat—obesity	0.0002	0.000677	CcSEcCtD
Leflunomide—Hypotension—Sibutramine—obesity	0.0002	0.000677	CcSEcCtD
Leflunomide—Cough—Bupropion—obesity	0.000199	0.000675	CcSEcCtD
Leflunomide—Paraesthesia—Orlistat—obesity	0.000198	0.000672	CcSEcCtD
Leflunomide—Pancytopenia—Topiramate—obesity	0.000198	0.000672	CcSEcCtD
Leflunomide—Hypertension—Bupropion—obesity	0.000197	0.000668	CcSEcCtD
Leflunomide—Dysuria—Topiramate—obesity	0.000195	0.000662	CcSEcCtD
Leflunomide—Neutropenia—Topiramate—obesity	0.000195	0.000662	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Sibutramine—obesity	0.000195	0.00066	CcSEcCtD
Leflunomide—Dyspepsia—Orlistat—obesity	0.000194	0.000659	CcSEcCtD
Leflunomide—Arthralgia—Bupropion—obesity	0.000194	0.000659	CcSEcCtD
Leflunomide—Myalgia—Bupropion—obesity	0.000194	0.000659	CcSEcCtD
Leflunomide—Chest pain—Bupropion—obesity	0.000194	0.000659	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Topiramate—obesity	0.000194	0.000658	CcSEcCtD
Leflunomide—Anxiety—Bupropion—obesity	0.000194	0.000656	CcSEcCtD
Leflunomide—Insomnia—Sibutramine—obesity	0.000193	0.000655	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000193	0.000654	CcSEcCtD
Leflunomide—Pollakiuria—Topiramate—obesity	0.000193	0.000654	CcSEcCtD
Leflunomide—Discomfort—Bupropion—obesity	0.000192	0.000651	CcSEcCtD
Leflunomide—Decreased appetite—Orlistat—obesity	0.000192	0.000651	CcSEcCtD
Leflunomide—Paraesthesia—Sibutramine—obesity	0.000192	0.00065	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Orlistat—obesity	0.000191	0.000646	CcSEcCtD
Leflunomide—Dyspnoea—Sibutramine—obesity	0.000191	0.000646	CcSEcCtD
Leflunomide—Fatigue—Orlistat—obesity	0.00019	0.000645	CcSEcCtD
Leflunomide—Dry mouth—Bupropion—obesity	0.00019	0.000644	CcSEcCtD
Leflunomide—Weight decreased—Topiramate—obesity	0.000189	0.00064	CcSEcCtD
Leflunomide—Pain—Orlistat—obesity	0.000189	0.00064	CcSEcCtD
Leflunomide—Hyperglycaemia—Topiramate—obesity	0.000188	0.000638	CcSEcCtD
Leflunomide—Dyspepsia—Sibutramine—obesity	0.000188	0.000638	CcSEcCtD
Leflunomide—Pneumonia—Topiramate—obesity	0.000187	0.000634	CcSEcCtD
Leflunomide—Anaphylactic shock—Bupropion—obesity	0.000186	0.000631	CcSEcCtD
Leflunomide—Infestation NOS—Topiramate—obesity	0.000186	0.000631	CcSEcCtD
Leflunomide—Infestation—Topiramate—obesity	0.000186	0.000631	CcSEcCtD
Leflunomide—Decreased appetite—Sibutramine—obesity	0.000186	0.00063	CcSEcCtD
Leflunomide—Infection—Bupropion—obesity	0.000185	0.000627	CcSEcCtD
Leflunomide—Stevens-Johnson syndrome—Topiramate—obesity	0.000185	0.000625	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Sibutramine—obesity	0.000185	0.000625	CcSEcCtD
Leflunomide—Renal failure—Topiramate—obesity	0.000183	0.00062	CcSEcCtD
Leflunomide—Pain—Sibutramine—obesity	0.000183	0.000619	CcSEcCtD
Leflunomide—Constipation—Sibutramine—obesity	0.000183	0.000619	CcSEcCtD
Leflunomide—Nervous system disorder—Bupropion—obesity	0.000183	0.000619	CcSEcCtD
Leflunomide—Neuropathy peripheral—Topiramate—obesity	0.000182	0.000618	CcSEcCtD
Leflunomide—Thrombocytopenia—Bupropion—obesity	0.000182	0.000618	CcSEcCtD
Leflunomide—Feeling abnormal—Orlistat—obesity	0.000182	0.000617	CcSEcCtD
Leflunomide—Tachycardia—Bupropion—obesity	0.000182	0.000616	CcSEcCtD
Leflunomide—Stomatitis—Topiramate—obesity	0.000181	0.000615	CcSEcCtD
Leflunomide—Skin disorder—Bupropion—obesity	0.000181	0.000613	CcSEcCtD
Leflunomide—Conjunctivitis—Topiramate—obesity	0.000181	0.000613	CcSEcCtD
Leflunomide—Urinary tract infection—Topiramate—obesity	0.000181	0.000613	CcSEcCtD
Leflunomide—Gastrointestinal pain—Orlistat—obesity	0.000181	0.000612	CcSEcCtD
Leflunomide—Hyperhidrosis—Bupropion—obesity	0.00018	0.00061	CcSEcCtD
Leflunomide—Anorexia—Bupropion—obesity	0.000178	0.000602	CcSEcCtD
Leflunomide—Haematuria—Topiramate—obesity	0.000177	0.000601	CcSEcCtD
Leflunomide—Feeling abnormal—Sibutramine—obesity	0.000176	0.000597	CcSEcCtD
Leflunomide—Epistaxis—Topiramate—obesity	0.000176	0.000595	CcSEcCtD
Leflunomide—Urticaria—Orlistat—obesity	0.000175	0.000595	CcSEcCtD
Leflunomide—Gastrointestinal pain—Sibutramine—obesity	0.000175	0.000592	CcSEcCtD
Leflunomide—Sinusitis—Topiramate—obesity	0.000175	0.000592	CcSEcCtD
Leflunomide—Abdominal pain—Orlistat—obesity	0.000175	0.000592	CcSEcCtD
Leflunomide—Body temperature increased—Orlistat—obesity	0.000175	0.000592	CcSEcCtD
Leflunomide—Hypotension—Bupropion—obesity	0.000174	0.00059	CcSEcCtD
Leflunomide—Agranulocytosis—Topiramate—obesity	0.000174	0.000589	CcSEcCtD
Leflunomide—Urticaria—Sibutramine—obesity	0.00017	0.000575	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Bupropion—obesity	0.00017	0.000575	CcSEcCtD
Leflunomide—Abdominal pain—Sibutramine—obesity	0.000169	0.000573	CcSEcCtD
Leflunomide—Body temperature increased—Sibutramine—obesity	0.000169	0.000573	CcSEcCtD
Leflunomide—Insomnia—Bupropion—obesity	0.000169	0.000571	CcSEcCtD
Leflunomide—Haemoglobin—Topiramate—obesity	0.000168	0.000569	CcSEcCtD
Leflunomide—Rhinitis—Topiramate—obesity	0.000168	0.000568	CcSEcCtD
Leflunomide—Paraesthesia—Bupropion—obesity	0.000167	0.000567	CcSEcCtD
Leflunomide—Haemorrhage—Topiramate—obesity	0.000167	0.000566	CcSEcCtD
Leflunomide—Hepatitis—Topiramate—obesity	0.000167	0.000566	CcSEcCtD
Leflunomide—Dyspnoea—Bupropion—obesity	0.000166	0.000563	CcSEcCtD
Leflunomide—Pharyngitis—Topiramate—obesity	0.000166	0.000562	CcSEcCtD
Leflunomide—Urinary tract disorder—Topiramate—obesity	0.000165	0.000559	CcSEcCtD
Leflunomide—Oedema peripheral—Topiramate—obesity	0.000165	0.000558	CcSEcCtD
Leflunomide—Connective tissue disorder—Topiramate—obesity	0.000164	0.000556	CcSEcCtD
Leflunomide—Dyspepsia—Bupropion—obesity	0.000164	0.000556	CcSEcCtD
Leflunomide—Urethral disorder—Topiramate—obesity	0.000164	0.000555	CcSEcCtD
Leflunomide—Hypersensitivity—Orlistat—obesity	0.000163	0.000551	CcSEcCtD
Leflunomide—Decreased appetite—Bupropion—obesity	0.000162	0.000549	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Bupropion—obesity	0.000161	0.000545	CcSEcCtD
Leflunomide—Fatigue—Bupropion—obesity	0.000161	0.000544	CcSEcCtD
Leflunomide—Pain—Bupropion—obesity	0.000159	0.00054	CcSEcCtD
Leflunomide—Constipation—Bupropion—obesity	0.000159	0.00054	CcSEcCtD
Leflunomide—Asthenia—Orlistat—obesity	0.000158	0.000537	CcSEcCtD
Leflunomide—Erythema multiforme—Topiramate—obesity	0.000158	0.000535	CcSEcCtD
Leflunomide—Hypersensitivity—Sibutramine—obesity	0.000157	0.000534	CcSEcCtD
Leflunomide—Pruritus—Orlistat—obesity	0.000156	0.00053	CcSEcCtD
Leflunomide—Eye disorder—Topiramate—obesity	0.000156	0.000529	CcSEcCtD
Leflunomide—Cardiac disorder—Topiramate—obesity	0.000155	0.000526	CcSEcCtD
Leflunomide—Feeling abnormal—Bupropion—obesity	0.000154	0.00052	CcSEcCtD
Leflunomide—Asthenia—Sibutramine—obesity	0.000153	0.00052	CcSEcCtD
Leflunomide—Gastrointestinal pain—Bupropion—obesity	0.000152	0.000516	CcSEcCtD
Leflunomide—Pruritus—Sibutramine—obesity	0.000151	0.000512	CcSEcCtD
Leflunomide—Diarrhoea—Orlistat—obesity	0.000151	0.000512	CcSEcCtD
Leflunomide—Immune system disorder—Topiramate—obesity	0.000151	0.000512	CcSEcCtD
Leflunomide—Mediastinal disorder—Topiramate—obesity	0.000151	0.00051	CcSEcCtD
Leflunomide—Chills—Topiramate—obesity	0.00015	0.000508	CcSEcCtD
Leflunomide—Urticaria—Bupropion—obesity	0.000148	0.000502	CcSEcCtD
Leflunomide—Alopecia—Topiramate—obesity	0.000148	0.0005	CcSEcCtD
Leflunomide—Abdominal pain—Bupropion—obesity	0.000147	0.000499	CcSEcCtD
Leflunomide—Body temperature increased—Bupropion—obesity	0.000147	0.000499	CcSEcCtD
Leflunomide—Mental disorder—Topiramate—obesity	0.000146	0.000496	CcSEcCtD
Leflunomide—Diarrhoea—Sibutramine—obesity	0.000146	0.000496	CcSEcCtD
Leflunomide—Dizziness—Orlistat—obesity	0.000146	0.000495	CcSEcCtD
Leflunomide—Malnutrition—Topiramate—obesity	0.000145	0.000493	CcSEcCtD
Leflunomide—Flatulence—Topiramate—obesity	0.000143	0.000486	CcSEcCtD
Leflunomide—Dysgeusia—Topiramate—obesity	0.000142	0.000483	CcSEcCtD
Leflunomide—Dizziness—Sibutramine—obesity	0.000141	0.000479	CcSEcCtD
Leflunomide—Back pain—Topiramate—obesity	0.000141	0.000477	CcSEcCtD
Leflunomide—Vomiting—Orlistat—obesity	0.00014	0.000476	CcSEcCtD
Leflunomide—Muscle spasms—Topiramate—obesity	0.00014	0.000474	CcSEcCtD
Leflunomide—Rash—Orlistat—obesity	0.000139	0.000472	CcSEcCtD
Leflunomide—Dermatitis—Orlistat—obesity	0.000139	0.000471	CcSEcCtD
Leflunomide—Headache—Orlistat—obesity	0.000138	0.000469	CcSEcCtD
Leflunomide—Hypersensitivity—Bupropion—obesity	0.000137	0.000465	CcSEcCtD
Leflunomide—Vision blurred—Topiramate—obesity	0.000137	0.000465	CcSEcCtD
Leflunomide—Vomiting—Sibutramine—obesity	0.000136	0.000461	CcSEcCtD
Leflunomide—Ill-defined disorder—Topiramate—obesity	0.000135	0.000457	CcSEcCtD
Leflunomide—Rash—Sibutramine—obesity	0.000135	0.000457	CcSEcCtD
Leflunomide—Dermatitis—Sibutramine—obesity	0.000135	0.000456	CcSEcCtD
Leflunomide—Anaemia—Topiramate—obesity	0.000134	0.000456	CcSEcCtD
Leflunomide—Headache—Sibutramine—obesity	0.000134	0.000454	CcSEcCtD
Leflunomide—Asthenia—Bupropion—obesity	0.000134	0.000453	CcSEcCtD
Leflunomide—Pruritus—Bupropion—obesity	0.000132	0.000447	CcSEcCtD
Leflunomide—Nausea—Orlistat—obesity	0.000131	0.000445	CcSEcCtD
Leflunomide—Malaise—Topiramate—obesity	0.000131	0.000445	CcSEcCtD
Leflunomide—Vertigo—Topiramate—obesity	0.000131	0.000443	CcSEcCtD
Leflunomide—Leukopenia—Topiramate—obesity	0.00013	0.000441	CcSEcCtD
Leflunomide—Palpitations—Topiramate—obesity	0.000129	0.000436	CcSEcCtD
Leflunomide—Diarrhoea—Bupropion—obesity	0.000127	0.000432	CcSEcCtD
Leflunomide—Nausea—Sibutramine—obesity	0.000127	0.00043	CcSEcCtD
Leflunomide—Cough—Topiramate—obesity	0.000127	0.00043	CcSEcCtD
Leflunomide—Hypertension—Topiramate—obesity	0.000126	0.000426	CcSEcCtD
Leflunomide—Chest pain—Topiramate—obesity	0.000124	0.00042	CcSEcCtD
Leflunomide—Arthralgia—Topiramate—obesity	0.000124	0.00042	CcSEcCtD
Leflunomide—Myalgia—Topiramate—obesity	0.000124	0.00042	CcSEcCtD
Leflunomide—Anxiety—Topiramate—obesity	0.000123	0.000418	CcSEcCtD
Leflunomide—Dizziness—Bupropion—obesity	0.000123	0.000418	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000123	0.000417	CcSEcCtD
Leflunomide—Discomfort—Topiramate—obesity	0.000122	0.000415	CcSEcCtD
Leflunomide—Dry mouth—Topiramate—obesity	0.000121	0.00041	CcSEcCtD
Leflunomide—Vomiting—Bupropion—obesity	0.000118	0.000402	CcSEcCtD
Leflunomide—Infection—Topiramate—obesity	0.000118	0.0004	CcSEcCtD
Leflunomide—Rash—Bupropion—obesity	0.000117	0.000398	CcSEcCtD
Leflunomide—Dermatitis—Bupropion—obesity	0.000117	0.000398	CcSEcCtD
Leflunomide—Headache—Bupropion—obesity	0.000117	0.000396	CcSEcCtD
Leflunomide—Nervous system disorder—Topiramate—obesity	0.000116	0.000395	CcSEcCtD
Leflunomide—Thrombocytopenia—Topiramate—obesity	0.000116	0.000394	CcSEcCtD
Leflunomide—Tachycardia—Topiramate—obesity	0.000116	0.000393	CcSEcCtD
Leflunomide—Skin disorder—Topiramate—obesity	0.000115	0.000391	CcSEcCtD
Leflunomide—Hyperhidrosis—Topiramate—obesity	0.000115	0.000389	CcSEcCtD
Leflunomide—Anorexia—Topiramate—obesity	0.000113	0.000384	CcSEcCtD
Leflunomide—Hypotension—Topiramate—obesity	0.000111	0.000376	CcSEcCtD
Leflunomide—Nausea—Bupropion—obesity	0.000111	0.000375	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Topiramate—obesity	0.000108	0.000367	CcSEcCtD
Leflunomide—Insomnia—Topiramate—obesity	0.000107	0.000364	CcSEcCtD
Leflunomide—Paraesthesia—Topiramate—obesity	0.000107	0.000361	CcSEcCtD
Leflunomide—Dyspnoea—Topiramate—obesity	0.000106	0.000359	CcSEcCtD
Leflunomide—Dyspepsia—Topiramate—obesity	0.000104	0.000354	CcSEcCtD
Leflunomide—Decreased appetite—Topiramate—obesity	0.000103	0.00035	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Topiramate—obesity	0.000102	0.000347	CcSEcCtD
Leflunomide—Fatigue—Topiramate—obesity	0.000102	0.000347	CcSEcCtD
Leflunomide—Constipation—Topiramate—obesity	0.000102	0.000344	CcSEcCtD
Leflunomide—Pain—Topiramate—obesity	0.000102	0.000344	CcSEcCtD
Leflunomide—Feeling abnormal—Topiramate—obesity	9.78e-05	0.000332	CcSEcCtD
Leflunomide—Gastrointestinal pain—Topiramate—obesity	9.71e-05	0.000329	CcSEcCtD
Leflunomide—Urticaria—Topiramate—obesity	9.43e-05	0.00032	CcSEcCtD
Leflunomide—Abdominal pain—Topiramate—obesity	9.38e-05	0.000318	CcSEcCtD
Leflunomide—Body temperature increased—Topiramate—obesity	9.38e-05	0.000318	CcSEcCtD
Leflunomide—Hypersensitivity—Topiramate—obesity	8.75e-05	0.000296	CcSEcCtD
Leflunomide—Asthenia—Topiramate—obesity	8.52e-05	0.000289	CcSEcCtD
Leflunomide—Pruritus—Topiramate—obesity	8.4e-05	0.000285	CcSEcCtD
Leflunomide—Diarrhoea—Topiramate—obesity	8.12e-05	0.000275	CcSEcCtD
Leflunomide—Dizziness—Topiramate—obesity	7.85e-05	0.000266	CcSEcCtD
Leflunomide—Vomiting—Topiramate—obesity	7.55e-05	0.000256	CcSEcCtD
Leflunomide—Rash—Topiramate—obesity	7.49e-05	0.000254	CcSEcCtD
Leflunomide—Dermatitis—Topiramate—obesity	7.48e-05	0.000253	CcSEcCtD
Leflunomide—Headache—Topiramate—obesity	7.44e-05	0.000252	CcSEcCtD
Leflunomide—Nausea—Topiramate—obesity	7.05e-05	0.000239	CcSEcCtD
Leflunomide—ABCG2—Metabolism—GOT1—obesity	1.44e-05	7.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PNLIP—obesity	1.44e-05	7.89e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SRD5A1—obesity	1.44e-05	7.89e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HSD11B1—obesity	1.43e-05	7.86e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—UCP3—obesity	1.43e-05	7.86e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—UCP2—obesity	1.43e-05	7.86e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ECHS1—obesity	1.43e-05	7.86e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NCOA1—obesity	1.42e-05	7.79e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADH1B—obesity	1.41e-05	7.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SDC3—obesity	1.4e-05	7.71e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP19A1—obesity	1.4e-05	7.68e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—STK11—obesity	1.4e-05	7.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—obesity	1.4e-05	7.67e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PIK3CD—obesity	1.4e-05	7.67e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—obesity	1.39e-05	7.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARGC1B—obesity	1.39e-05	7.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ACSL1—obesity	1.39e-05	7.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPAM—obesity	1.39e-05	7.61e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SERPINE1—obesity	1.38e-05	7.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—obesity	1.38e-05	7.55e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HK2—obesity	1.37e-05	7.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—STS—obesity	1.37e-05	7.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP26B1—obesity	1.37e-05	7.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—obesity	1.36e-05	7.44e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PCK1—obesity	1.35e-05	7.39e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HADH—obesity	1.35e-05	7.39e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FADS1—obesity	1.35e-05	7.39e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TYK2—obesity	1.34e-05	7.38e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARD—obesity	1.34e-05	7.37e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RHOA—obesity	1.33e-05	7.32e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—obesity	1.32e-05	7.27e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PIK3R1—obesity	1.32e-05	7.24e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—obesity	1.32e-05	7.24e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC27A1—obesity	1.32e-05	7.22e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ACP5—obesity	1.31e-05	7.18e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—COMT—obesity	1.3e-05	7.14e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—obesity	1.29e-05	7.09e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FABP4—obesity	1.29e-05	7.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GLUL—obesity	1.29e-05	7.08e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GNB3—obesity	1.28e-05	7.04e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARGC1A—obesity	1.28e-05	7.04e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—obesity	1.28e-05	7.01e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—G6PD—obesity	1.28e-05	7e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HK1—obesity	1.26e-05	6.92e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SREBF2—obesity	1.26e-05	6.92e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—obesity	1.26e-05	6.91e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GNAS—obesity	1.25e-05	6.86e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	1.24e-05	6.82e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOB—obesity	1.22e-05	6.71e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ECHS1—obesity	1.22e-05	6.71e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—UCP3—obesity	1.22e-05	6.71e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HSD11B1—obesity	1.22e-05	6.71e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—UCP2—obesity	1.22e-05	6.71e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PIK3CB—obesity	1.22e-05	6.68e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MTOR—obesity	1.22e-05	6.68e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPA—obesity	1.22e-05	6.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADH1B—obesity	1.2e-05	6.6e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPIN1—obesity	1.19e-05	6.54e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—obesity	1.19e-05	6.51e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPAM—obesity	1.18e-05	6.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARGC1B—obesity	1.18e-05	6.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ACSL1—obesity	1.18e-05	6.5e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—obesity	1.17e-05	6.42e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LPL—obesity	1.17e-05	6.41e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA5—obesity	1.17e-05	6.4e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PCK1—obesity	1.15e-05	6.31e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FADS1—obesity	1.15e-05	6.31e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HADH—obesity	1.15e-05	6.31e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PIK3CA—obesity	1.15e-05	6.3e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GPX1—obesity	1.14e-05	6.25e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—obesity	1.13e-05	6.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—obesity	1.13e-05	6.21e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ACP5—obesity	1.12e-05	6.14e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC22A1—obesity	1.11e-05	6.11e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CLOCK—obesity	1.11e-05	6.11e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	1.11e-05	6.09e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CD36—obesity	1.11e-05	6.09e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—obesity	1.1e-05	6.06e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	1.1e-05	6.04e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	1.1e-05	6.02e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—G6PD—obesity	1.09e-05	5.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SULT2A1—obesity	1.08e-05	5.95e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GLP1R—obesity	1.08e-05	5.95e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HK1—obesity	1.08e-05	5.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SREBF2—obesity	1.08e-05	5.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—obesity	1.08e-05	5.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DPYD—obesity	1.07e-05	5.86e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—obesity	1.06e-05	5.81e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—obesity	1.05e-05	5.77e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPA—obesity	1.04e-05	5.71e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARA—obesity	1.03e-05	5.66e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK8—obesity	1.03e-05	5.65e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PRKAR2B—obesity	1.03e-05	5.64e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DCN—obesity	1.02e-05	5.6e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPIN1—obesity	1.02e-05	5.59e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—obesity	1.02e-05	5.58e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1e-05	5.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	1e-05	5.49e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AGT—obesity	9.99e-06	5.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA5—obesity	9.97e-06	5.47e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CPT1A—obesity	9.92e-06	5.44e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—obesity	9.79e-06	5.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NAMPT—obesity	9.73e-06	5.34e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAV1—obesity	9.7e-06	5.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	9.69e-06	5.32e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOA1—obesity	9.68e-06	5.31e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	9.67e-06	5.31e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LIPC—obesity	9.67e-06	5.31e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCK—obesity	9.67e-06	5.31e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOC3—obesity	9.61e-06	5.27e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	9.54e-06	5.24e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC22A1—obesity	9.51e-06	5.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CLOCK—obesity	9.51e-06	5.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	9.49e-06	5.21e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT3—obesity	9.41e-06	5.17e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	9.4e-06	5.16e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	9.38e-06	5.15e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AKT1—obesity	9.38e-06	5.15e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CETP—obesity	9.33e-06	5.12e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GLP1R—obesity	9.27e-06	5.09e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SULT2A1—obesity	9.27e-06	5.09e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SDC1—obesity	9.22e-06	5.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DPYD—obesity	9.12e-06	5e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1C3—obesity	9.08e-06	4.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SCARB1—obesity	8.93e-06	4.9e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3CG—obesity	8.84e-06	4.85e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	8.81e-06	4.84e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PRKAR2B—obesity	8.78e-06	4.82e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MYC—obesity	8.75e-06	4.8e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—obesity	8.73e-06	4.79e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DCN—obesity	8.72e-06	4.78e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	8.7e-06	4.77e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SREBF1—obesity	8.67e-06	4.76e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	8.57e-06	4.7e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—obesity	8.53e-06	4.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CPT1A—obesity	8.48e-06	4.65e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT2—obesity	8.44e-06	4.63e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—obesity	8.41e-06	4.62e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—obesity	8.37e-06	4.59e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	8.32e-06	4.57e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NAMPT—obesity	8.32e-06	4.56e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	8.27e-06	4.54e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LIPC—obesity	8.26e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCK—obesity	8.26e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FASN—obesity	8.26e-06	4.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—BCHE—obesity	8.22e-06	4.51e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOC3—obesity	8.21e-06	4.51e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	8.15e-06	4.47e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CETP—obesity	7.97e-06	4.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2E1—obesity	7.93e-06	4.35e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SDC1—obesity	7.88e-06	4.33e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NQO1—obesity	7.84e-06	4.3e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3CD—obesity	7.77e-06	4.26e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1C3—obesity	7.75e-06	4.26e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	7.68e-06	4.21e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—obesity	7.67e-06	4.21e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SCARB1—obesity	7.63e-06	4.19e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	7.61e-06	4.18e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	7.53e-06	4.13e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC2A4—obesity	7.52e-06	4.13e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCG—obesity	7.52e-06	4.13e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	7.43e-06	4.08e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PIK3CA—obesity	7.43e-06	4.07e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYCS—obesity	7.42e-06	4.07e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SREBF1—obesity	7.41e-06	4.07e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3R1—obesity	7.34e-06	4.03e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—obesity	7.34e-06	4.03e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT1—obesity	7.28e-06	4e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT1—obesity	7.28e-06	4e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT2—obesity	7.21e-06	3.96e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NCOA1—obesity	7.17e-06	3.94e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	7.11e-06	3.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—STK11—obesity	7.07e-06	3.88e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP19A1—obesity	7.07e-06	3.88e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FASN—obesity	7.06e-06	3.87e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—BCHE—obesity	7.03e-06	3.86e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2E1—obesity	6.78e-06	3.72e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3CB—obesity	6.77e-06	3.72e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—obesity	6.71e-06	3.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NQO1—obesity	6.7e-06	3.68e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—obesity	6.57e-06	3.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—COMT—obesity	6.57e-06	3.61e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	6.56e-06	3.6e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	6.5e-06	3.57e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARGC1A—obesity	6.48e-06	3.56e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GNB3—obesity	6.48e-06	3.56e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—obesity	6.45e-06	3.54e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCG—obesity	6.43e-06	3.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC2A4—obesity	6.43e-06	3.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYCS—obesity	6.34e-06	3.48e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GNAS—obesity	6.31e-06	3.46e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT1—obesity	6.22e-06	3.42e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT1—obesity	6.22e-06	3.42e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOB—obesity	6.18e-06	3.39e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NCOA1—obesity	6.13e-06	3.36e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT1—obesity	6.07e-06	3.33e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—STK11—obesity	6.04e-06	3.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP19A1—obesity	6.04e-06	3.32e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPL—obesity	5.9e-06	3.24e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPX1—obesity	5.76e-06	3.16e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—COMT—obesity	5.62e-06	3.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CD36—obesity	5.61e-06	3.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GNB3—obesity	5.54e-06	3.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARGC1A—obesity	5.54e-06	3.04e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—obesity	5.51e-06	3.03e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GNAS—obesity	5.39e-06	2.96e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—obesity	5.31e-06	2.92e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOB—obesity	5.28e-06	2.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARA—obesity	5.21e-06	2.86e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AGT—obesity	5.05e-06	2.77e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPL—obesity	5.04e-06	2.77e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—obesity	4.95e-06	2.71e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPX1—obesity	4.92e-06	2.7e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAV1—obesity	4.9e-06	2.69e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA1—obesity	4.89e-06	2.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CD36—obesity	4.79e-06	2.63e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.68e-06	2.57e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—obesity	4.54e-06	2.49e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3CG—obesity	4.46e-06	2.45e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARA—obesity	4.45e-06	2.44e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AGT—obesity	4.31e-06	2.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—obesity	4.31e-06	2.36e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—obesity	4.25e-06	2.33e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—obesity	4.23e-06	2.32e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—obesity	4.23e-06	2.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAV1—obesity	4.19e-06	2.3e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA1—obesity	4.18e-06	2.29e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3CA—obesity	4.13e-06	2.27e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4e-06	2.2e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3CD—obesity	3.92e-06	2.15e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—obesity	3.87e-06	2.13e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3CG—obesity	3.81e-06	2.09e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3R1—obesity	3.71e-06	2.03e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—obesity	3.71e-06	2.03e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—obesity	3.68e-06	2.02e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—obesity	3.63e-06	1.99e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—obesity	3.61e-06	1.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3CB—obesity	3.42e-06	1.88e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—obesity	3.39e-06	1.86e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKT1—obesity	3.37e-06	1.85e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3CD—obesity	3.35e-06	1.84e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—obesity	3.31e-06	1.82e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3R1—obesity	3.17e-06	1.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—obesity	3.17e-06	1.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3CB—obesity	2.92e-06	1.6e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—obesity	2.9e-06	1.59e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3CA—obesity	2.09e-06	1.14e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3CA—obesity	1.78e-06	9.78e-06	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKT1—obesity	1.7e-06	9.35e-06	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKT1—obesity	1.46e-06	7.99e-06	CbGpPWpGaD
